financetom
Business
financetom
/
Business
/
Amneal Pharmaceuticals Says US FDA Approves Generic Drug Application for Propofol
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amneal Pharmaceuticals Says US FDA Approves Generic Drug Application for Propofol
Aug 20, 2024 6:02 AM

08:32 AM EDT, 08/20/2024 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Tuesday that its abbreviated new drug application for the single-dose formulation of anesthetic propofol has gained approval from the US Food and Drug Administration.

The company said it expects to launch propofol in Q4.

Shares of the company were up 1.4% in recent Tuesday premarket activity.

Price: 8.26, Change: +0.11, Percent Change: +1.35

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Super Micro Computer Places 2 Employees on Administrative Leave Over Alleged Export-Control Breaches
Super Micro Computer Places 2 Employees on Administrative Leave Over Alleged Export-Control Breaches
Mar 20, 2026
04:05 AM EDT, 03/20/2026 (MT Newswires) -- Super Micro Computer ( SMCI ) said late Thursday it placed two of its employees on administrative leave and terminated a contractor, effective immediately, after US prosecutors indicted all three individuals over allegedly conspiring to commit export-control violations. The company said it was informed by the US Attorney's Office for the Southern District...
Market Chatter: Eli Lilly Alzheimer's Drug to be Reconsidered by UK Health Regulator
Market Chatter: Eli Lilly Alzheimer's Drug to be Reconsidered by UK Health Regulator
Mar 20, 2026
04:13 AM EDT, 03/20/2026 (MT Newswires) -- Eli Lilly's ( LLY ) Alzheimer's drug will be reassessed by the National Institute for Health and Care Excellence after a successful appeal against a prior decision blocking its use in the state-run National Health Service, Bloomberg reported Friday. The regulator will review earlier guidance that found the benefits of donanemab, marketed as...
BRIEF-German Cartel Office Gives Preliminary Approval To Adobe's Planned Acquisition Of Semrush Holdings
BRIEF-German Cartel Office Gives Preliminary Approval To Adobe's Planned Acquisition Of Semrush Holdings
Mar 20, 2026
March 20 (Reuters) - Adobe Inc ( ADBE ): * GERMAN CARTEL OFFICE: GIVES PRELIMINARY APPROVAL TO ADOBE'S PLANNED ACQUISITION OF SEMRUSH HOLDINGS Source text: Further company coverage: ...
CRA International Insider Sold Shares Worth $1,166,265, According to a Recent SEC Filing
CRA International Insider Sold Shares Worth $1,166,265, According to a Recent SEC Filing
Mar 20, 2026
04:15 AM EDT, 03/20/2026 (MT Newswires) -- Paul A Maleh, Director, President and Chief Executive Officer, on March 17, 2026, sold 7,500 shares in CRA International ( CRAI ) for $1,166,265. Following the Form 4 filing with the SEC, Maleh has control over a total of 115,113 common shares of the company, with 115,113 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1053706/000137916026000013/xslF345X05/form4-03192026_090322.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved